ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,168.20
-1.70%
S&P ASX All Technology
3,794.30
-2.54%
Brent Oil
72.92
0.25%
US Dollar vs AUD
1.601
-0.67%
Bitcoin
102,413.98
2.35%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Clearmind Medicine Inc (CMND)

  7. Clearmind Medicine Inc (CMND) News

CMND

Clearmind Medicine (CMND)

Clearmind Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CMND
DateTimeSourceHeadlineSymbolCompany
17/12/202400:37GlobeNewswire Inc.Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ FormatNASDAQ:CMNDClearmind Medicine Inc
10/12/202409:12Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CMNDClearmind Medicine Inc
07/12/202409:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
21/11/202408:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
11/10/202407:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
10/10/202423:07GlobeNewswire Inc.Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical SiteNASDAQ:CMNDClearmind Medicine Inc
01/10/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CMNDClearmind Medicine Inc
27/09/202406:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
25/09/202406:30Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CMNDClearmind Medicine Inc
17/09/202406:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
17/09/202406:06GlobeNewswire Inc.Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination TherapyNASDAQ:CMNDClearmind Medicine Inc
17/09/202406:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
13/09/202406:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
12/09/202422:20GlobeNewswire Inc.Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD TreatmentNASDAQ:CMNDClearmind Medicine Inc
07/09/202406:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
06/09/202421:55GlobeNewswire Inc.Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination TreatmentNASDAQ:CMNDClearmind Medicine Inc
06/09/202421:55GlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination TreatmentNASDAQ:CMNDClearmind Medicine Inc
30/08/202406:25GlobeNewswire Inc.Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination TreatmentNASDAQ:CMNDClearmind Medicine Inc
22/08/202406:11GlobeNewswire Inc.Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior TreatmentNASDAQ:CMNDClearmind Medicine Inc
17/08/202406:14GlobeNewswire Inc.Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental DisordersNASDAQ:CMNDClearmind Medicine Inc
06/08/202422:57GlobeNewswire Inc.Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss DrugNASDAQ:CMNDClearmind Medicine Inc
06/08/202422:57GlobeNewswire Inc.SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss DrugNASDAQ:CMNDClearmind Medicine Inc
31/07/202421:44GlobeNewswire Inc.Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its Groundbreaking ResearchNASDAQ:CMNDClearmind Medicine Inc
19/07/202421:55GlobeNewswire Inc.Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage ProductNASDAQ:CMNDClearmind Medicine Inc
16/07/202423:02GlobeNewswire Inc.Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with its Innovative Treatment for AlcoholismNASDAQ:CMNDClearmind Medicine Inc
16/07/202420:03GlobeNewswire Inc.SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight LossNASDAQ:CMNDClearmind Medicine Inc
16/07/202420:03GlobeNewswire Inc.Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-lossNASDAQ:CMNDClearmind Medicine Inc
12/07/202422:02GlobeNewswire Inc.Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 ConferenceNASDAQ:CMNDClearmind Medicine Inc
28/06/202421:55GlobeNewswire Inc.Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors TreatmentNASDAQ:CMNDClearmind Medicine Inc
20/06/202421:57GlobeNewswire Inc.Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD TreatmentNASDAQ:CMNDClearmind Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:CMND

Your Recent History

SPI
SP500
S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
SUN
Suncorp
NYSE
KO
Coca Cola
NYSE
JPM
JP Morgan Chase
ASX
WPL
Woodside Petroleum
ASX
WBC
Westpac Banking
COIN
DOGEUSD
Dogecoin
ASX
XFL
S&P ASX 50
ASX
BHP
BHP
ASX
QBE
QBE Insurance
FX
AUDCAD
AUD vs CAD
ASX
NCM
Newcrest Mining
COIN
SOLUSD
Solana
COIN
XRPUSD
Ripple
ASX
MQG
Macquarie
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads